Bio-Techne Corporation

US$72.78As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TECHHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 11.47%
Div yield 0.44%
ROE 8.32%
Biotechnology
Beta (5Y) 1.27
PE TTM 66.21
TSR TTM 16.98%
Mkt cap US$11.43B
ROIC 9.41%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$89
22.79%
(91.12%)
Hold 1|2|4|9|4
2Q26
3Q26
4Q26
1Q27
Earnings per share$
1.15
1.12
1.20
1.28
26.33%
22.60%
22.89%
20.25%
Revenue$B
1.365
1.355
1.424
1.477
10.46%
9.33%
14.27%
14.11%
Peers (US$11.43B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.312
—
—
EBIT/Intx
7.306
0.296
0.299
Own earn%
(94.42)
49.91
49.27
Sh yield%
13.24
46.76
43.60
Owners
Insiders/Inst%
11.82
56.67
Short interest%
5.98
SBC / revenue%
1.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
1–9
$1 testx
−0.2
Incr. ROIC%
70